Anas Zayad | Health Professions | Innovative Research Award

Innovative Research Award

Anas Zayad
Hamad Medical Corporation, Qatar

Anas Zayad
Affiliation Hamad Medical Corporation
Country Qatar
Scopus ID 59286140000
Documents 12
Citations 5
h-index 2
Subject Area Health Professions
Event International Popular Scientist Awards
ORCID 0009-0006-7537-0112

The Innovative Research Award recognizes scholarly achievement, research productivity, and contributions to scientific knowledge. This academic profile presents an overview of the research activities of Anas Zayad, affiliated with Hamad Medical Corporation, Qatar. The profile summarizes publication metrics, research specialization, and scholarly impact using publicly available bibliometric information while maintaining a neutral academic perspective.[1]

Abstract

Anas Zayad has contributed to scholarly research within the field of Health Professions through peer-reviewed scientific publications indexed in Scopus. Bibliometric indicators demonstrate an emerging research profile supported by indexed publications, citations, and measurable scholarly visibility. These indicators provide objective evidence of academic activity and form part of the evaluation commonly considered in research recognition programs.[1]

Keywords

Innovative Research Award; Health Professions; Scientific Publications; Scopus Author; Research Impact; Citation Analysis; Hamad Medical Corporation; Academic Recognition; International Popular Scientist Awards.

Introduction

Modern scientific evaluation increasingly relies upon peer-reviewed publications, citation analysis, and research quality indicators to assess scholarly productivity. Bibliometric databases such as Scopus provide standardized information regarding publication records and research influence across numerous disciplines. These metrics assist institutions, collaborators, and award committees in understanding research performance while complementing expert peer evaluation.[2]

Research Profile

The available Scopus profile identifies Anas Zayad as an author affiliated with Hamad Medical Corporation, Qatar. The profile includes 12 indexed publications, an h-index of 5, and 2 recorded citations at the time of profile preparation. Research activities are primarily associated with Health Professions and related interdisciplinary healthcare research.[1]

Research Contributions

  • Participation in peer-reviewed scientific research within Health Professions.
  • Contribution to internationally indexed scholarly publications.
  • Support for evidence-based healthcare research and academic dissemination.
  • Development of research outputs contributing to scientific literature.

Publications

The author’s publication portfolio comprises peer-reviewed journal articles indexed in Scopus. These publications collectively contribute to the dissemination of scientific knowledge within healthcare and Health Professions. Individual articles may include Digital Object Identifiers (DOIs) assigned by their respective publishers, ensuring persistent scholarly identification and accessibility.[3]

Research Impact

Research impact can be evaluated using several complementary indicators, including publication volume, citation frequency, and the h-index. The available bibliometric profile demonstrates continued scholarly activity and measurable academic visibility. While citation metrics evolve over time as publications receive additional recognition, indexed outputs provide a transparent record of research engagement.[2]

Award Suitability

Based on publicly available bibliometric information, Anas Zayad demonstrates characteristics commonly evaluated for academic recognition programs, including peer-reviewed publications, international indexing, and measurable research metrics. Final award decisions remain dependent upon the official eligibility criteria, peer assessment, documentation, and evaluation procedures established by the International Popular Scientist Awards.[4]

Conclusion

This academic profile provides a structured overview of Anas Zayad’s research activity using recognized bibliometric information. The combination of indexed publications, citation indicators, and institutional affiliation illustrates ongoing participation in scientific research within Health Professions while reflecting a commitment to scholarly communication and evidence-based academic advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Anas Zayad, Author ID 59286140000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59286140000
  2. Elsevier. (n.d.). Scopus Content Policy and Bibliometric Indicators.
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.
  4. International Popular Scientist Awards. (n.d.). Award Information and Evaluation Guidelines.
    https://popularscientist.com/

Nuru Noor | Health Professions | Best Researcher Award

Dr. Nuru Noor | Health Professions | Best Researcher Award

Clinical Lecturer University of Cambridge United Kingdom

Dr. Nuru Noor, a distinguished academic gastroenterologist, combines clinical expertise in Inflammatory Bowel Disease (IBD) with an academic focus on innovative drug development and clinical trials. Based at the University of Cambridge and Cambridge University Hospitals, UK, Dr. Noor strives to improve the quality of life for IBD patients by translating research findings into impactful clinical applications. 🌟

Profile

Google Scholar

Orcid

Education

Dr. Noor holds an impressive array of qualifications: a BSc, BMBS, MPhil, MRCP, PhD, and a Postgraduate Certificate in Medical Education (PGC Med Ed). Their academic journey reflects a strong commitment to advancing both clinical and academic excellence. 🎓

Experience

Dr. Noor is currently a Clinical Lecturer in Gastroenterology at the University of Cambridge and a Postdoctoral Researcher in Clinical Trials at the Medical Research Council (MRC) Clinical Trials Unit, University College London. They serve as Principal Investigator for PROFILE, a multi-center RCT for Crohn’s disease patients, and contribute to several prestigious committees, including NICE medical expert reviews and the NIHR EME funding committee. 🩺

Research Interests

Dr. Noor’s research focuses on developing innovative approaches to drug development and clinical trials, particularly for IBD. This includes precision medicine, trial methodology, and improving treatment outcomes for patients through cutting-edge translational research. 🔬

Awards

Dr. Noor’s outstanding contributions have been recognized with several prestigious awards, including:

  • British Society of Gastroenterology Clinical Research Award (2024) 🏆
  • Academy of Medical Sciences Best Research Abstract Award (2024)
  • ECCO Investigator-Initiated Study of the Year Team Award (2024)
  • Royal College of Physicians of Edinburgh Croom Medal (2022)

Publications Top Notes:

Dr. Noor has authored over 60 PubMed-indexed publications and contributed to 3 book chapters. Their works span highly regarded journals in gastroenterology, clinical trials, and IBD research. Key publications include:

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …

ECCO guidelines on therapeutics in ulcerative colitis: medical treatment

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global …

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open …